Cell Impact AB (publ) (STO:CI)

Cell Impact AB Statistics

Total Valuation

Cell Impact AB has a market cap or net worth of SEK 37.71 million. The enterprise value is 72.77 million.

Market Cap	37.71M
Enterprise Value	72.77M

Important Dates

The last earnings date was Friday, August 22, 2025.

Earnings Date	Aug 22, 2025
Ex-Dividend Date	n/a

Share Statistics

Cell Impact AB has 294.58 million shares outstanding. The number of shares has increased by 82.49% in one year.

Current Share Class	294.58M
Shares Outstanding	294.58M
Shares Change (YoY)	+82.49%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.79%
Owned by Institutions (%)	4.27%
Float	286.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.04
PB Ratio	0.22
P/TBV Ratio	0.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.74
EV / Sales	5.87
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.21

Financial Position

The company has a current ratio of 1.34, with a Debt / Equity ratio of 0.21.

Current Ratio	1.34
Quick Ratio	0.29
Debt / Equity	0.21
Debt / EBITDA	n/a
Debt / FCF	-1.09
Interest Coverage	-39.61

Financial Efficiency

Return on equity (ROE) is -45.54% and return on invested capital (ROIC) is -24.01%.

Return on Equity (ROE)	-45.54%
Return on Assets (ROA)	-22.74%
Return on Invested Capital (ROIC)	-24.01%
Return on Capital Employed (ROCE)	-52.50%
Revenue Per Employee	354,029
Profits Per Employee	-2.83M
Employee Count	41
Asset Turnover	0.05
Inventory Turnover	0.36

Taxes

Income Tax	-495,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -94.64% in the last 52 weeks. The beta is 1.56, so Cell Impact AB's price volatility has been higher than the market average.

Beta (5Y)	1.56
52-Week Price Change	-94.64%
50-Day Moving Average	0.19
200-Day Moving Average	0.78
Relative Strength Index (RSI)	30.97
Average Volume (20 Days)	1,772,472

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cell Impact AB had revenue of SEK 12.39 million and -98.90 million in losses. Loss per share was -1.47.

Revenue	12.39M
Gross Profit	-2.60M
Operating Income	-98.15M
Pretax Income	-99.39M
Net Income	-98.90M
EBITDA	-78.00M
EBIT	-98.15M
Loss Per Share	-1.47

Balance Sheet

The company has 955,000 in cash and 36.02 million in debt, giving a net cash position of -35.07 million or -0.12 per share.

Cash & Cash Equivalents	955,000
Total Debt	36.02M
Net Cash	-35.07M
Net Cash Per Share	-0.12
Equity (Book Value)	175.34M
Book Value Per Share	2.52
Working Capital	12.76M

Cash Flow

In the last 12 months, operating cash flow was -28.92 million and capital expenditures -4.07 million, giving a free cash flow of -32.99 million.

Operating Cash Flow	-28.92M
Capital Expenditures	-4.07M
Free Cash Flow	-32.99M
FCF Per Share	-0.11

Margins

Gross Margin	-20.99%
Operating Margin	-792.09%
Pretax Margin	-802.12%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Cell Impact AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-82.49%
Shareholder Yield	n/a
Earnings Yield	-262.28%
FCF Yield	-87.49%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 25, 2025. It was a reverse split with a ratio of 0.1.

Last Split Date	Aug 25, 2025
Split Type	Reverse
Split Ratio	0.1

Scores

Cell Impact AB has an Altman Z-Score of -4.01 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.01
Piotroski F-Score	2